Table 3 Correlations between expression levels of mRNA of ANO1 and clinical parameters.

From: Detection of ANO1 mRNA in PBMCs is a promising method for GISTs diagnosis

 

overall (n = 81)

ANO1 positive(n = 55)

ANO1 negative(n = 26)

p value

N

%

N

%

Age

≤55

38

24

63

14

37

 

>55

43

31

73

12

27

0.47

Gender

male

40

28

70

12

30

 

female

41

27

66

14

34

0.83

Tumor location

Stomach

49

35

71

14

29

 

Small intestine

22

13

59

9

41

 

Duodenum

6

4

66

2

34

 

Colorectum

4

3

75

1

25

0.7

Histopathological

Epithelioid

38

29

76

9

34

 

Spindle

30

18

60

12

40

 

Mixed

13

8

61

5

39

0.3

Tumor size

≤5 cm

29

14

48

15

52

 

5–10 cm

36

28

78

8

22

*0.018

>10 cm

16

13

81

3

19

 
  1. ANO1 expression was significantly higher in the group with tumor size (>10 cm, positive rate, 81%) than group with tumor size (5–10 cm, positive rate, 78%) and group with tumor size (≤5 cm, positive rate, 48%). No significant correlation was found between ANO1 expression and other clinical parameters.
  2. Values of *p < 0.05 were considered statistically significant.